Wernicke's Encephalopathy in Chronic Alcoholics
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Vitamin and Mineral Requirements in Human Nutrition
P000i-00xx 3/12/05 8:54 PM Page i Vitamin and mineral requirements in human nutrition Second edition VITPR 3/12/05 16:50 Page ii WHO Library Cataloguing-in-Publication Data Joint FAO/WHO Expert Consultation on Human Vitamin and Mineral Requirements (1998 : Bangkok, Thailand). Vitamin and mineral requirements in human nutrition : report of a joint FAO/WHO expert consultation, Bangkok, Thailand, 21–30 September 1998. 1.Vitamins — standards 2.Micronutrients — standards 3.Trace elements — standards 4.Deficiency diseases — diet therapy 5.Nutritional requirements I.Title. ISBN 92 4 154612 3 (LC/NLM Classification: QU 145) © World Health Organization and Food and Agriculture Organization of the United Nations 2004 All rights reserved. Publications of the World Health Organization can be obtained from Market- ing and Dissemination, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permis- sion to reproduce or translate WHO publications — whether for sale or for noncommercial distri- bution — should be addressed to Publications, at the above address (fax: +41 22 791 4806; e-mail: [email protected]), or to Chief, Publishing and Multimedia Service, Information Division, Food and Agriculture Organization of the United Nations, 00100 Rome, Italy. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization and the Food and Agriculture Organization of the United Nations concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. -
341 Nutrient Deficiency Or Disease Definition/Cut-Off Value
10/2019 341 Nutrient Deficiency or Disease Definition/Cut-off Value Any currently treated or untreated nutrient deficiency or disease. These include, but are not limited to, Protein Energy Malnutrition, Scurvy, Rickets, Beriberi, Hypocalcemia, Osteomalacia, Vitamin K Deficiency, Pellagra, Xerophthalmia, and Iron Deficiency. Presence of condition diagnosed, documented, or reported by a physician or someone working under a physician’s orders, or as self-reported by applicant/participant/caregiver. See Clarification for more information about self-reporting a diagnosis. Participant Category and Priority Level Category Priority Pregnant Women 1 Breastfeeding Women 1 Non-Breastfeeding Women 6 Infants 1 Children 3 Justification Nutrient deficiencies or diseases can be the result of poor nutritional intake, chronic health conditions, acute health conditions, medications, altered nutrient metabolism, or a combination of these factors, and can impact the levels of both macronutrients and micronutrients in the body. They can lead to alterations in energy metabolism, immune function, cognitive function, bone formation, and/or muscle function, as well as growth and development if the deficiency is present during fetal development and early childhood. The Centers for Disease Control and Prevention (CDC) estimates that less than 10% of the United States population has nutrient deficiencies; however, nutrient deficiencies vary by age, gender, and/or race and ethnicity (1). For certain segments of the population, nutrient deficiencies may be as high as one third of the population (1). Intake patterns of individuals can lead to nutrient inadequacy or nutrient deficiencies among the general population. Intakes of nutrients that are routinely below the Dietary Reference Intakes (DRI) can lead to a decrease in how much of the nutrient is stored in the body and how much is available for biological functions. -
Magnesium Deficiency: a Possible Cause of Thiamine Refractoriness in Wernicke-Korsakoff Encephalopathy
J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.37.8.959 on 1 August 1974. Downloaded from Journal of Neurology, Neurosurgery, and Psychiatry, 1974, 37, 959-962 Magnesium deficiency: a possible cause of thiamine refractoriness in Wernicke-Korsakoff encephalopathy D. C. TRAVIESA From the Department ofNeurology, University ofMiami School of Medicine, Miami, Florida, U.S.A. SYNOPSIS The determination of blood transketolase before and serially after thiamine administra- tion, and the response of clinical symptomatology after thiamine are reported in two normo- magnesaemic patients and one hypomagnesaemic patient with acute Wernicke-Korsakoff encephalopathy. The response of the depressed blood transketolase and the clinical symptoms was retarded in the hypomagnesaemic patient. Correction of hypomagnesaemia was accompanied by the recovery of blood transketolase activity and total clearing of the ophthalmoplegia in this patient, guest. Protected by copyright. suggesting that hypomagnesaemia may be a cause of the occasional thiamine refractoriness of these patients. Previous studies have shown that the clinical vestibular nuclei (Prickett, 1934; Dreyfus and entity of Wernicke-Korsakoff encephalopathy is Victor, 1961; Dreyfus, 1965). related to an exclusive deficiency of thiamine (Phillips et al., 1952). Furthermore, improvement Blood transketolase activity is markedly re- in clinical symptoms, once the syndrome has de- duced in patients with Wernicke-Korsakoff veloped, occurs only with the repletion of thi- encephalopathy and serial assays in these patients amine. It is this obvious and seemingly pure usually reveal a rapid and essentially complete causal relationship of thiamine deficiency and recovery of the reduced blood transketolase Wernicke-Korsakoff encephalopathy that neces- activity after the parental administration of sitates the total understanding of thiamine thiamine (Brin, 1962; Dreyfus, 1962). -
Magnesium: the Forgotten Electrolyte—A Review on Hypomagnesemia
medical sciences Review Magnesium: The Forgotten Electrolyte—A Review on Hypomagnesemia Faheemuddin Ahmed 1,* and Abdul Mohammed 2 1 OSF Saint Anthony Medical Center, 5666 E State St, Rockford, IL 61108, USA 2 Advocate Illinois Masonic Medical Center, 833 W Wellington Ave, Chicago, IL 60657, USA; [email protected] * Correspondence: [email protected] Received: 20 February 2019; Accepted: 2 April 2019; Published: 4 April 2019 Abstract: Magnesium is the fourth most abundant cation in the body and the second most abundant intracellular cation. It plays an important role in different organ systems at the cellular and enzymatic levels. Despite its importance, it still has not received the needed attention either in the medical literature or in clinical practice in comparison to other electrolytes like sodium, potassium, and calcium. Hypomagnesemia can lead to many clinical manifestations with some being life-threatening. The reported incidence is less likely than expected in the general population. We present a comprehensive review of different aspects of magnesium physiology and hypomagnesemia which can help clinicians in understanding, identifying, and treating this disorder. Keywords: magnesium; proton pump inhibitors; diuretics; hypomagnesemia 1. Introduction Magnesium is one of the most abundant cation in the body as well as an abundant intracellular cation. It plays an important role in molecular, biochemical, physiological, and pharmacological functions in the body. The importance of magnesium is well known, but still it is the forgotten electrolyte. The reason for it not getting the needed attention is because of rare symptomatology until levels are really low and also because of a lack of proper understanding of magnesium physiology. -
Mechanism of Hypokalemia in Magnesium Deficiency
SCIENCE IN RENAL MEDICINE www.jasn.org Mechanism of Hypokalemia in Magnesium Deficiency Chou-Long Huang*† and Elizabeth Kuo* *Department of Medicine, †Charles and Jane Pak Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center, Dallas, Texas ABSTRACT deficiency is likely associated with en- ϩ Magnesium deficiency is frequently associated with hypokalemia. Concomitant hanced renal K excretion. To support magnesium deficiency aggravates hypokalemia and renders it refractory to treat- this idea, Baehler et al.5 showed that ad- ment by potassium. Herein is reviewed literature suggesting that magnesium ministration of magnesium decreases ϩ deficiency exacerbates potassium wasting by increasing distal potassium secre- urinary K excretion and increases se- ϩ tion. A decrease in intracellular magnesium, caused by magnesium deficiency, rum K levels in a patient with Bartter releases the magnesium-mediated inhibition of ROMK channels and increases disease with combined hypomagnesemia potassium secretion. Magnesium deficiency alone, however, does not necessarily and hypokalemia. Similarly, magnesium ϩ cause hypokalemia. An increase in distal sodium delivery or elevated aldosterone replacement alone (without K ) in- ϩ levels may be required for exacerbating potassium wasting in magnesium creases serum K levels in individuals deficiency. who have hypokalemia and hypomag- nesemia and receive thiazide treatment.6 J Am Soc Nephrol 18: 2649–2652, 2007. doi: 10.1681/ASN.2007070792 Magnesium administration decreased urinary Kϩ excretion in these individuals (Dr. Charles Pak, personal communica- Hypokalemia is among the most fre- cin B, cisplatin, etc. Concomitant magne- tion, UT Southwestern Medical Center quently encountered fluid and electro- sium deficiency has long been appreci- at Dallas, July 13, 2007). -
Thiamine for Prevention and Treatment of Wernicke-Korsakoff Syndrome in People Who Abuse Alcohol (Review) Copyright © 2013 the Cochrane Collaboration
Thiamine for prevention and treatment of Wernicke- Korsakoff Syndrome in people who abuse alcohol (Review) Day E, Bentham PW, Callaghan R, Kuruvilla T, George S This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library 2013, Issue 7 http://www.thecochranelibrary.com Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcohol (Review) Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. TABLE OF CONTENTS HEADER....................................... 1 ABSTRACT ...................................... 1 PLAINLANGUAGESUMMARY . 2 BACKGROUND .................................... 2 OBJECTIVES ..................................... 3 METHODS ...................................... 4 RESULTS....................................... 6 DISCUSSION ..................................... 7 AUTHORS’CONCLUSIONS . 8 ACKNOWLEDGEMENTS . 9 REFERENCES ..................................... 9 CHARACTERISTICSOFSTUDIES . 10 DATAANDANALYSES. 14 Analysis 1.1. Comparison 1 Thiamine (any dose) vs thiamine 5mg/day, Outcome 1 performance on a delayed alternation test. ..................................... 15 APPENDICES ..................................... 15 WHAT’SNEW..................................... 18 HISTORY....................................... 19 CONTRIBUTIONSOFAUTHORS . 19 DECLARATIONSOFINTEREST . 19 SOURCESOFSUPPORT . 20 INDEXTERMS .................................... 20 Thiamine for prevention and treatment of Wernicke-Korsakoff -
A Retrospective Case Series of Thiamine Deficiency in Non
Journal of Clinical Medicine Article A Retrospective Case Series of Thiamine Deficiency in Non-Alcoholic Hospitalized Veterans: An Important Cause of Delirium and Falling? Elisabeth Mates 1,2,* , Deepti Alluri 3, Tailer Artis 2 and Mark S. Riddle 1,2 1 Medicine Department, Veterans Affairs Sierra Nevada Healthcare System, Reno, NV 89502, USA; [email protected] 2 School of Medicine, University of Nevada, Reno, NV 89502, USA; [email protected] 3 Sound Physicians, Lutheran Hospital, Fort Wayne, IN 46804, USA; [email protected] * Correspondence: [email protected] Abstract: Thiamine deficiency (TD) in non-alcoholic hospitalized patients causes a variety of non- specific symptoms. Studies suggest it is not rare in acutely and chronically ill individuals in high income countries and is underdiagnosed. Our aim is to demonstrate data which help define the risk factors and constellation of symptoms of TD in this population. We describe 36 cases of TD in hospitalized non-alcoholic veterans over 5 years. Clinical and laboratory data were extracted by chart review +/− 4 weeks of plasma thiamine level 7 nmol/L or less. Ninety-seven percent had two or more chronic inflammatory conditions (CICs) and 83% had one or more acute inflammatory conditions (AICs). Of possible etiologies of TD 97% had two or more of: insufficient intake, inflammatory stress, or increased losses. Seventy-five percent experienced 5% or more weight loss. Ninety-two percent had symptoms with the most common being weakness or falling (75%) followed by neuropsychiatric Citation: Mates, E.; Alluri, D.; Artis, manifestations (72%), gastrointestinal dysfunction (53%), and ataxia (42%). We conclude that TD is T.; Riddle, M.S. -
Thiamine and Magnesium Deficiencies
Medical Hypotheses 84 (2015) 129–134 Contents lists available at ScienceDirect Medical Hypotheses journal homepage: www.elsevier.com/locate/mehy Thiamine and magnesium deficiencies: Keys to disease ⇑ D. Lonsdale Associate Emeritus, Cleveland Clinic, Cleveland, OH, United States article info abstract Article history: Thiamine deficiency (TD) is accepted as the cause of beriberi because of its action in the metabolism of Received 21 September 2014 simple carbohydrates, mainly as the rate limiting cofactor for the dehydrogenases of pyruvate and alpha- Accepted 6 December 2014 ketoglutarate, both being critical to the action of the citric acid cycle. Transketolase, dependent on thiamine and magnesium, occurs twice in the oxidative pentose pathway, important in production of reducing equivalents. Thiamine is also a cofactor in the dehydrogenase complex in the degradation of the branched chain amino acids, leucine, isoleucine and valine. In spite of these well accepted facts, the overall clinical effects of TD are still poorly understood. Because of the discovery of 2-hydroxyacyl- CoA lyase (HACL1) as the first peroxisomal enzyme in mammals found to be dependent on thiamine pyrophosphate (TPP) and the ability of thiamine to bind with prion protein, these factors should improve our clinical approach to TD. HACL1 has two important roles in alpha oxidation, the degradation of phy- tanic acid and shortening of 2-hydroxy long-chain fatty acids so that they can be degraded further by beta oxidation. The downstream effects of a lack of efficiency in this enzyme would be expected to be critical in normal brain metabolism. Although TD has been shown experimentally to produce reversible damage to mitochondria and there are many other causes of mitochondrial dysfunction, finding TD as the poten- tial biochemical lesion would help in differential diagnosis. -
Vitamins and Minerals for Energy, Fatigue and Cognition: a Narrative Review of the Biochemical and Clinical Evidence
nutrients Review Vitamins and Minerals for Energy, Fatigue and Cognition: A Narrative Review of the Biochemical and Clinical Evidence Anne-Laure Tardy 1,*, Etienne Pouteau 1 , Daniel Marquez 2, Cansu Yilmaz 3 and Andrew Scholey 4 1 Sanofi Consumer Healthcare, Global Medical Nutritionals, 94250 Gentilly, France; Etienne.Pouteau@sanofi.com 2 Sanofi Consumer Healthcare, 04000 México City, Mexico; Daniel.Marquez@sanofi.com 3 Sanofi Consumer Healthcare, 34394 Be¸sikta¸sIstanbul, Turkey; cansu.yilmaz@sanofi.com 4 Centre for Human Psychopharmacology, Swinburne University, Victoria, VIC 3122, Australia; [email protected] * Correspondence: Anne-Laure.Tardy@sanofi.com Received: 23 December 2019; Accepted: 11 January 2020; Published: 16 January 2020 Abstract: Vitamins and minerals are essential to humans as they play essential roles in a variety of basic metabolic pathways that support fundamental cellular functions. In particular, their involvement in energy-yielding metabolism, DNA synthesis, oxygen transport, and neuronal functions makes them critical for brain and muscular function. These, in turn, translate into effects on cognitive and psychological processes, including mental and physical fatigue. This review is focused on B vitamins (B1, B2, B3, B5, B6, B8, B9 and B12), vitamin C, iron, magnesium and zinc, which have recognized roles in these outcomes. It summarizes the biochemical bases and actions of these micronutrients at both the molecular and cellular levels and connects them with cognitive and psychological symptoms, as well as manifestations of fatigue that may occur when status or supplies of these micronutrients are not adequate. Keywords: B vitamins; vitamin C; iron; magnesium; zinc; energy production; mental and physical fatigue; anemia; cognition; mood. -
Magnesium Deficiency of Foliage Plants J
Plant Pathology Circular No. 354 Fla. Dept. Agric. & Consumer Serv. July-August 1992 Division of Plant Industry MAGNESIUM DEFICIENCY OF FOLIAGE PLANTS J. J. McRitchie1 Symptoms of magnesium (Mg) deficiency are among the most widely observed nutritional problems in Florida foliage plant production (1,2). Magnesium is a key constituent of chlorophyll, the green pigment in plants which is responsible for phytosynthesis. It is also active in enzyme systems (4). Soilless artificial growing media frequently used in Florida are low in Mg, requiring a fertilizer program supplying Mg. Many plant nutrients are readily leached from Florida's sandy soils (3). SYMPTOMS: Magnesium, not to be confused with manganese (Mn), is easily translocated within the plant (4). It is preferentially moved to rapidly differentiating terminal areas of the plant; thus deficiencies are evident in older leaves first. Calcium in plants exists in a sensitive balance with magnesium and some other nutrients. What appears to be an excess of calcium may be the result of a lack of magnesium; whereas, an apparent excess of magnesium may respond to the addition of calcium (4). In most foliage plants, chlorosis progresses inward and downward from the upper leaf margins, leaving an inverted V- shaped green area at the leaf base and a V-shaped area at the leaf tip (Fig. 1). Eventually, rusty brown necrosis begins where chlorosis was first apparent. The chlorosis which develops is a bronze yellow color giving Mg deficiency the name "bronzing disease" (2). Many of the foliage ornamentals with pinnately veined leaves (such as Philodendron scandens subsp. oxycardium) and the palms (such as Chrysalidocarpus lutescens) exhibit this symptomatology (1,2). -
291.89 Other 291.9 Unspecified Alcohol-Induced Mental Disorders 303.00 Acute Alcoholic Intoxication, Unspecified 303.01 Acut
H C 116 Aortic and peripheral arterial embolism or thrombosis 291.89 Other UP ANDFACTS FIGURES: STATISTICS (arterial blood clots) 291.9 Unspecified alcohol-induced mental disorders 117 Other circulatory disease (other blood vessel disease) 303.00 Acute alcoholic intoxication, unspecified 119 Varicose veins of lower extremity (varicose veins in leg) 303.01 Acute alcoholic intoxication, continuous 120 Hemorrhoids 303.02 Acute alcoholic intoxication, episodic 121 Other diseases of veins and lymphatics (lymph system) 303.03 Acute alcoholic intoxication, in remission 303.90 Other and unspecified alcohol dependence, unspecified EXHIBIT 2.6 303.91 Other and unspecified alcohol dependence, continuous Diabetes CCS categories: 303.92 Other and unspecified alcohol dependence, episodic 49 Diabetes mellitus without complication 303.93 Other and unspecified alcohol dependence, in remission O 50 Diabetes mellitus with complications 305.00 Alcohol abuse, unspecified N ho 305.01 Alcohol abuse, continuous SPITA EXHIBIT 2.7 305.02 Alcohol abuse, episodic L - 305.03 Alcohol abuse, in remission B Pressure sore ICD-9-CM codes: ASED CARE IN T 707.0 Decubitus ulcer 357.5 Alcoholic polyneuropathy 707.00 Decubitus ulcer, unspecified site 425.5 Alcoholic cardiomyopathy 707.01 Decubitus ulcer, elbow 535.3 Alcoholic gastritis 707.02 Decubitus ulcer, upper back 535.31 Alcoholic gastritis, with hemorrhage H 707.03 Decubitus ulcer, lower back 571.0 Alcoholic fatty liver E UNITED 2005 STATES, 707.04 Decubitus ulcer, hip 571.1 Acute alcoholic hepatitis 707.05 Decubitus -
Human Alcohol-Related Neuropathology
Acta Neuropathol (2014) 127:71–90 DOI 10.1007/s00401-013-1233-3 REVIEW Human alcohol-related neuropathology Suzanne M. de la Monte · Jillian J. Kril Received: 15 October 2013 / Revised: 12 December 2013 / Accepted: 13 December 2013 / Published online: 27 December 2013 © Springer-Verlag Berlin Heidelberg 2013 Abstract Alcohol-related diseases of the nervous sys- on glia, myelin, and the microvasculature. Alcohol also tem are caused by excessive exposures to alcohol, with has devastating neurotoxic and teratogenic effects on the or without co-existing nutritional or vitamin deficiencies. developing brain in association with fetal alcohol spectrum Toxic and metabolic effects of alcohol (ethanol) vary with disorder/fetal alcohol syndrome. Alcohol impairs function brain region, age/developmental stage, dose, and duration of neurons and glia, disrupting a broad array of functions of exposures. In the mature brain, heavy chronic or binge including neuronal survival, cell migration, and glial cell alcohol exposures can cause severe debilitating diseases (astrocytes and oligodendrocytes) differentiation. Further of the central and peripheral nervous systems, and skele- progress is needed to better understand the pathophysiol- tal muscle. Most commonly, long-standing heavy alcohol ogy of this exposure-related constellation of nervous sys- abuse leads to disproportionate loss of cerebral white mat- tem diseases and better correlate the underlying pathology ter and impairments in executive function. The cerebellum with in vivo imaging and biochemical